HR 796 ยท Second Chance for Moms Act
Referred to the House Committee on Energy and Commerce.
- Introduced
- Jan 28, 2025
- Latest action
- Jan 28, 2025
- Sponsor
- Rep. Mary E. Miller [R-IL-15]
- Policy area
- Health
- Cosponsors
- 13
Summary
Second Chance for Moms Act of 2025 This bill requires labeling of the drug mifepristone to include certain information about the hormone progesterone and establishes a related telephone hotline. (Mifepristone is a drug that is approved to end pregnancies through 10 weeks gestation when used in conjunction with the drug misoprostol. The procedure is often referred to as medication abortion or the abortion pill.)
Recent actions
- Jan 28, 2025 Referred to the House Committee on Energy and Commerce.
- Jan 28, 2025 Introduced in House
- Jan 28, 2025 Introduced in House
Votes
No recorded votes are available for this bill.